Wordt geladen...
Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population‐based study
BACKGROUND: Theoretically, the estrogen deprivation induced by aromatase inhibitors (AIs) might cause ischemic heart disease, but empiric studies have shown mixed results. We aimed to compare AIs and tamoxifen with regard to cardiovascular events among older breast cancer patients outside of clinica...
Bewaard in:
| Gepubliceerd in: | Clin Cardiol |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wiley Periodicals, Inc.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6344290/ https://ncbi.nlm.nih.gov/pubmed/30443921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23114 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|